TY - JOUR
T1 - Longitudinal assessment of neuroradiologic features in wolfram syndrome
AU - Samara, A.
AU - Lugar, H. M.
AU - Hershey, T.
AU - Shimony, J. S.
N1 - Funding Information:
The research reported in this publication was supported by National Institute on Drug Abuse grant Nos. 5T32DA007261-27, HD070855 (T. Hershey, Principal Investigator), U54 HD087011 (Intellectual and Developmental Disabilities Research Center at Washington University), UL1 RR024992 (Clinical and Translational Science Awards), DK020579 (Diabetes Research Center); the George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; the Snow Foundation; the American Diabetes Association; Mallinckrodt Institute of Radiology; and the McDonnell Center for Systems Neuroscience.
Funding Information:
Received June 26, 2020; accepted after revision August 6. From the Departments of Psychiatry (A.S., H.M.L.) and Neurology (T.H.) and Mallinckrodt Institute of Radiology (T.H., J.S.S.), Washington University School of Medicine, St. Louis, Missouri. The research reported in this publication was supported by National Institute on Drug Abuse grant Nos. 5T32DA007261–27, HD070855 (T. Hershey, Principal Investigator), U54 HD087011 (Intellectual and Developmental Disabilities Research Center at Washington University), UL1 RR024992 (Clinical and Translational Science Awards), DK020579 (Diabetes Research Center); the George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; the Snow Foundation; the American Diabetes Association; Mallinckrodt Institute of Radiology; and the McDonnell Center for Systems Neuroscience.
Funding Information:
Disclosures: Amjad Samara—RELATED: Grant: National Institute on Drug Abuse, Comments: Amjad Samara is a postdoctoral scholar supported by the National Institute on Drug Abuse grant No. 5T32DA007261–27. Heather M. Lugar— RELATED: Grant: I receive payment via grants from the National Institutes of Health; UNRELATED: Employment: I receive payment via grants from National Institutes of Health; Grants/Grants Pending: I receive payment via grants from the National Institutes of Health. Tamara Hershey—RELATED: Grant: National Institutes of Health*; Support for Travel to Meetings for the Study or Other Purposes: National Institutes of Health*; UNRELATED: Employment: Washington University School of Medicine; Grants/Grants Pending: National Institutes of Health.* *Money paid to the institution.
Publisher Copyright:
© 2020 American Society of Neuroradiology. All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - BACKGROUND AND PURPOSE: Wolfram syndrome is a rare genetic disease with characteristic brain involvement. We reviewed the brain MR images of patients with Wolfram syndrome to determine the frequency and characteristics of common neuroradiologic findings. MATERIALS AND METHODS: We retrospectively reviewed the imaging data of patients with genetically-confirmed Wolfram syndrome who had been recruited to the Washington University Wolfram Syndrome Research Clinic. These patients were evaluated between 2010 and 2019 with annual MRIs, along with other measures. MR images were assessed for clinical neuroradiologic signs at each individual's first and last follow-up visits to characterize the frequency, rate of progression, and clinical correlations of these signs. RESULTS: We included 30 patients (13 males/17 females; average age at first visit, 14 years; average age at last visit, 19 years). The median duration of follow-up was 5 years (range, 2-9 years). The most common findings were an absent or diminished posterior pituitary bright spot (first, 53%; last, 70%), T1/T2 pons signal abnormalities (first, 53%; last, 67%), optic nerve atrophy (first, 30%; last, 80%), white matter T2 hyperintensities (first, 27%; last, 35%), and cerebellar atrophy (first, 23%; last, 70%). CONCLUSIONS: Patients with Wolfram syndrome present characteristic neuroradiologic findings that involve the posterior pituitary gland, optic nerves, white matter, brain stem, and cerebellum. These abnormal findings appear at an early age and tend to increase in frequency with time. However, the neurologic significance and neuropathologic mechanisms of each sign require more investigation. Neuroradiologists should be aware of the pattern of these features in Wolfram syndrome.
AB - BACKGROUND AND PURPOSE: Wolfram syndrome is a rare genetic disease with characteristic brain involvement. We reviewed the brain MR images of patients with Wolfram syndrome to determine the frequency and characteristics of common neuroradiologic findings. MATERIALS AND METHODS: We retrospectively reviewed the imaging data of patients with genetically-confirmed Wolfram syndrome who had been recruited to the Washington University Wolfram Syndrome Research Clinic. These patients were evaluated between 2010 and 2019 with annual MRIs, along with other measures. MR images were assessed for clinical neuroradiologic signs at each individual's first and last follow-up visits to characterize the frequency, rate of progression, and clinical correlations of these signs. RESULTS: We included 30 patients (13 males/17 females; average age at first visit, 14 years; average age at last visit, 19 years). The median duration of follow-up was 5 years (range, 2-9 years). The most common findings were an absent or diminished posterior pituitary bright spot (first, 53%; last, 70%), T1/T2 pons signal abnormalities (first, 53%; last, 67%), optic nerve atrophy (first, 30%; last, 80%), white matter T2 hyperintensities (first, 27%; last, 35%), and cerebellar atrophy (first, 23%; last, 70%). CONCLUSIONS: Patients with Wolfram syndrome present characteristic neuroradiologic findings that involve the posterior pituitary gland, optic nerves, white matter, brain stem, and cerebellum. These abnormal findings appear at an early age and tend to increase in frequency with time. However, the neurologic significance and neuropathologic mechanisms of each sign require more investigation. Neuroradiologists should be aware of the pattern of these features in Wolfram syndrome.
UR - http://www.scopus.com/inward/record.url?scp=85097814428&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A6831
DO - 10.3174/ajnr.A6831
M3 - Article
C2 - 33122205
AN - SCOPUS:85097814428
SN - 0195-6108
VL - 41
SP - 2364
EP - 2369
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 12
ER -